Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Accounts Payables: 2020-2023

Historic Accounts Payables for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $2.1 million.

  • Immuneering's Accounts Payables rose 0.09% to $1.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.9 million, marking a year-over-year increase of 0.09%. This contributed to the annual value of $2.1 million for FY2023, which is 33.06% down from last year.
  • Immuneering's Accounts Payables amounted to $2.1 million in FY2023, which was down 33.06% from $3.2 million recorded in FY2022.
  • Over the past 5 years, Immuneering's Accounts Payables peaked at $3.2 million during FY2022, and registered a low of $1.4 million during FY2021.
  • Moreover, its 3-year median value for Accounts Payables was $2.1 million (2023), whereas its average is $2.2 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first spiked by 126.24% in 2022, then plummeted by 33.06% in 2023.
  • Over the past 4 years, Immuneering's Accounts Payables (Yearly) stood at $1.5 million in 2020, then dropped by 5.82% to $1.4 million in 2021, then soared by 126.24% to $3.2 million in 2022, then plummeted by 33.06% to $2.1 million in 2023.